CLINICAL_TRIALS
trial_result
· 2011-03-24
Clinical Trial Update: Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery [Phase 4]
Summary
Phase 4 trial evaluating 0.3% Hypromellose Eyedrops for efficacy and tolerability in patients undergoing LASIK; results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Dry Eye | Phase 4 | Status: COMPLETED | Results posted: 2011-03-24